A detailed history of North Star Investment Management Corp. transactions in Organon & Co. stock. As of the latest transaction made, North Star Investment Management Corp. holds 1,110 shares of OGN stock, worth $17,893. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,110
Previous 1,105 0.45%
Holding current value
$17,893
Previous $22,000 4.55%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$18.65 - $23.03 $93 - $115
5 Added 0.45%
1,110 $21,000
Q2 2024

Aug 05, 2024

SELL
$17.45 - $21.96 $2,094 - $2,635
-120 Reduced 9.8%
1,105 $22,000
Q1 2024

Apr 30, 2024

SELL
$13.78 - $18.8 $24,817 - $33,858
-1,801 Reduced 59.52%
1,225 $23,000
Q4 2023

Jan 10, 2024

BUY
$10.95 - $17.32 $1,379 - $2,182
126 Added 4.34%
3,026 $43,000
Q3 2023

Nov 06, 2023

SELL
$16.59 - $23.77 $14,964 - $21,440
-902 Reduced 23.72%
2,900 $50,000
Q2 2023

Aug 02, 2023

BUY
$19.27 - $24.63 $96 - $123
5 Added 0.13%
3,802 $79,000
Q1 2023

Apr 27, 2023

BUY
$21.42 - $32.08 $23,369 - $34,999
1,091 Added 40.32%
3,797 $89,000
Q4 2022

Jan 11, 2023

SELL
$23.31 - $28.61 $1,118 - $1,373
-48 Reduced 1.74%
2,706 $0
Q3 2022

Nov 02, 2022

SELL
$23.4 - $34.25 $33,906 - $49,628
-1,449 Reduced 34.48%
2,754 $64,000
Q2 2022

Jul 19, 2022

SELL
$31.66 - $38.9 $1,583 - $1,945
-50 Reduced 1.18%
4,203 $142,000
Q1 2022

May 03, 2022

SELL
$30.45 - $39.36 $6,973 - $9,013
-229 Reduced 5.11%
4,253 $149,000
Q4 2021

Feb 07, 2022

SELL
$28.67 - $37.13 $3,325 - $4,307
-116 Reduced 2.52%
4,482 $136,000
Q3 2021

Oct 20, 2021

BUY
$28.63 - $35.64 $131,640 - $163,872
4,598 New
4,598 $151,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.1B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.